InsiderTrades

Form 4 for MET MetLife

Accepted 2026-02-26 00:00:00 ET · period of report 2026-02-24 · accession 0001714199-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2026-02-26 2026-02-24 MET TADROS RAMY Pres, U.S. Business F - Tax $75.34 -2,299 222.0K -1% -$173.2K
M 2026-02-26 2026-02-24 MET TADROS RAMY Pres, U.S. Business A - Grant — +42.9K 224.3K +24% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-24 F D 2,299 $75.34 221,985 D — —
2 Common Common Stock 2026-02-24 A A 19,910 — 201,278 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan.
3 Common Common Stock 2026-02-24 A A 23,006 — 224,284 D — — (F2) Shares acquired and earned from the determination of the performance factor for and payout of 2023-2025 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. The reporting person deferred 80% of these shares under the MetLife Leadership Deferred Compensation Plan, which allows eligible employees to defer receipt of such shares for a specific period of time.